Park Ha Biological Technology Co., Ltd. (PHH) Comparison with companies in other sectors?

Park Ha Biological Technology Co., Ltd. has a share price of 26.37M. You can analyze Park Ha Biological Technology Co., Ltd. (PHH) competitors across different market sectors through stock heatmaps.

What are PHH's NET and operating margins?

Park Ha Biological Technology Co., Ltd. (PHH) operating margin is around 0.33, and net profit margin is approximately 0.20 as of the latest reports.

In what way does PHH's earnings per share (EPS) trend reflect its financial momentum?

Park Ha Biological Technology Co., Ltd. (PHH) EPS is 0.02 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for Park Ha Biological Technology Co., Ltd. is 41.40, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for Park Ha Biological Technology Co., Ltd.?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for Park Ha Biological Technology Co., Ltd. like P/E which is 45.82, P/B which is 14.56, and PEG which is 0.46. Compare them with sector averages to evaluate if the stock is priced fairly.

Park Ha Biological Technology Co., Ltd.

PHH•NASDAQ

Consumer Defensive

Household & Personal Products

$0.83

$-0.01(-1.25%)

Fundamental Analysis of Park Ha Biological Technology Co., Ltd. (PHH)

Comprehensive financial metrics and ratios analysis

EPS (TTM)

$0.02

P/E Ratio

41.40

ROE

0.38%

Net Margin

0.20%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$21.84M

Shares OutstandingTotal number of shares issued

$26.37M

Book Value/ShareNet worth per share

$0.06

Revenue/ShareAnnual revenue per share

$0.09

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$0.02

Net MarginNet income as percentage of revenue

20.09%

Operating MarginOperating income as percentage of revenue

33.32%

ROEReturn on shareholders' equity

38.003%

ROAReturn on total assets

15.52%

ROCEReturn on capital employed

50.92%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$0.03

Cash/ShareCash and equivalents per share

$0.02

FCF YieldFree cash flow as percentage of market cap

3.97%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

Dividend YieldAnnual dividend as percentage of stock price

Financial Ratios Analysis data is not available for PHHFinancial Ratios Analysis details for PHH are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for PHHSector Benchmarking details for PHH are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for Park Ha Biological Technology Co., Ltd. Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of Park Ha Biological Technology Co., Ltd.. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account Park Ha Biological Technology Co., Ltd.'s unique business strengths and challenges.

Key Financial Metrics for Park Ha Biological Technology Co., Ltd.

For Park Ha Biological Technology Co., Ltd., essential financial indicators include EPS 0.02, PE 41.40, and ROE 0.38. These key ratios reveal insights into Park Ha Biological Technology Co., Ltd.'s profitability, valuation, and operational health. Understanding these metrics enables you to compare Park Ha Biological Technology Co., Ltd. with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of Park Ha Biological Technology Co., Ltd.

Metrics like Net Margin 20.09% and ROA 15.52% shed light on how well Park Ha Biological Technology Co., Ltd. is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether Park Ha Biological Technology Co., Ltd. can sustain its operations and continue growing in the future.

Valuation and Market Position of Park Ha Biological Technology Co., Ltd.

Using ratios such as P/B Ratio 14.56 and PEG Ratio 0.46, investors can assess whether Park Ha Biological Technology Co., Ltd. is appropriately valued based on its financials and growth potential. These figures, combined with Park Ha Biological Technology Co., Ltd.'s market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for Park Ha Biological Technology Co., Ltd.

Financial health indicators, such as Debt/Equity Ratio 0.05 and Cash Flow $0.03, provide a snapshot of Park Ha Biological Technology Co., Ltd.'s ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like Park Ha Biological Technology Co., Ltd., is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for Park Ha Biological Technology Co., Ltd.

Investing in Park Ha Biological Technology Co., Ltd. based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at Park Ha Biological Technology Co., Ltd. focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;